People who later experienced persistent shortness of breath or fatigue after a SARS-CoV-2 infection were already taking ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

COVID infections, even if mild or asymptomatic, may be causing long-term cellular and organ damage, as well as increasing ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Between April 2020 and December 2022, over 535,000 people in Germany downloaded and activated the Corona Data Donation App ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

The following is a summary of “A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 ...